[1]茅溢恒.幽门螺杆菌抗体、胃泌素17、胃蛋白酶原等联合检测 在体检人群胃疾病筛查中的意义[J].医学信息,2018,31(11):22-24.[doi:10.3969/j.issn.1006-1959.2018.11.007]
　MAO Yi-heng.The Significance of Combined Detection of Helicobacter Pylori Antibody,Gastrin 17, Pepsinogen,etc.in Gastric Disease Screening in Physical Examination Population[J].Journal of Medical Information,2018,31(11):22-24.[doi:10.3969/j.issn.1006-1959.2018.11.007]
点击复制

幽门螺杆菌抗体、胃泌素17、胃蛋白酶原等联合检测 在体检人群胃疾病筛查中的意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年11期
页码:
22-24
栏目:
出版日期:
2018-06-01

文章信息/Info

Title:
The Significance of Combined Detection of Helicobacter Pylori Antibody,Gastrin 17, Pepsinogen,etc.in Gastric Disease Screening in Physical Examination Population
文章编号:
1006-1959（2018）11-0022-03
作者:
茅溢恒
南京医科大学附属无锡人民医院体检中心，江苏 无锡 214023
Author(s):
MAO Yi-heng
Physical Examination Center of Wuxi People's Hospital Affiliated to Nanjing Medical University,Wuxi 214023,Jiangsu,China
关键词:
胃疾病; 幽门螺杆菌抗体; 胃泌素17; 胃蛋白酶原
Keywords:
Key words：Gastric disease; Helicobacter pylori antibody; Gastrin 17; Pepsinogen
分类号:
R735.2
DOI:
10.3969/j.issn.1006-1959.2018.11.007
文献标志码:
A
摘要:
目的 探讨分析幽门螺杆菌抗体、胃泌素17、胃蛋白酶原Ⅰ、Ⅱ及PGR联合检测在体检人群胃疾病筛查中的意义。方法 选取2016年1月~2017年12月来我院体检中心选择同时包含胃镜、胃泌素17、胃蛋白酶原及幽门螺杆菌抗体检查项目的受检者271例，分为经胃镜检查（部分行活检病理）证实的胃溃疡组49例，萎缩性胃炎组86例，癌前病变和胃癌组36例，经胃镜检查无胃疾病或仅有浅表性胃炎的对照组100例。采用放免技术测定体检人群血清中幽门螺杆菌抗体、胃泌素17、胃蛋白酶原Ⅰ、Ⅱ及其比值，同时行胃镜检查，胃镜下活检的病例均以病理诊断为准，对血清学、胃镜以及病理结果进行统计学分析。结果 胃癌前病变及胃癌组患者的五项指标中PGⅠ、PGR均低于其他各组，G-17水平、Hp-Ab阳性率均高于其他各组，差异有统计学意义（P＜0.05）。萎缩性胃炎组的G-17水平低于其他各组，差异有统计学意义（P＜0.05）。胃溃疡组中G-17和Hp-Ab阳性率的结果与对照组比较，差异有统计学意义（P＜0.05）。结论 幽门螺杆菌抗体、胃泌素17、胃蛋白酶原Ⅰ、Ⅱ及PGR的阳性率与胃疾病不同种类及严重程度密切相关，其联合检测在体检人群胃疾病的筛查、鉴别方面有着重要意义。
Abstract:
Abstract：Objective To explore the significance of combined detection of Helicobacter pylori antibody,gastrin 17,pepsinogen I,II,and PGR in gastric screening for physical examination.Methods From January 2016 to December 2017,we selected 271 patients with gastroscope,gastrin 17,pepsinogen,and Helicobacter pylori antibody screening items from our physical examination center and were divided into gastroscopic examinations(partially biopsy pathology)confirmed 49 cases of gastric ulcer group,86 cases of atrophic gastritis group,36 cases of precancerous lesion and gastric cancer group,and 100 cases of gastroscopic examination without gastric disease or superficial gastritis in the control group.The radioimmunoassay was used to determine the levels of Helicobacter pylori antibody, gastrin 17,pepsinogen I,II and its ratio in the serum of the physical examination population.At the same time,gastroscopy and endoscopic biopsy were all based on pathological diagnosis.Serological and gastroscopy were used and pathological results were analyzed statistically.Results The PGI and PGR in the five indicators of gastric precancerous lesions and gastric cancer patients were lower than those in other groups.The levels of G-17 and Hp-Ab positive were higher than those in other groups,and the difference was statistically significant(P<0.05).The level of G-17 in atrophic gastritis group was lower than that in other groups,and the difference was statistically significant(P<0.05).The positive rates of G-17 and Hp-Ab in gastric ulcer group were significantly different from those in the control group,the difference was statistically significant(P<0.05).Conclusion The positive rate of Helicobacter pylori antibody, gastrin 17,pepsinogen I,II and PGR is closely related to the different types and severity of gastric diseases.The joint detection is of great significance in screening and identification of gastric diseases in the physical examination population.

参考文献/References:

[1]赵建业,朱春平,李兆申.血清胃蛋白酶原、胃泌素-17、幽门螺杆菌抗体检测对萎缩性胃炎和胃癌的诊断价值[J].胃肠病学,2016,21(6):376-379. [2]俞媛洁,蔡欧,谭诗云.胃癌癌前状态与早期胃癌的诊断[J].医学新知,2016,26(1):14-16. [3]房殿春.胃癌前病变的概念、类型、病理特征和临床意义[J].医学与哲学,2015,36(22):10-12. [4]李守英,徐同磊,徐红.早期胃癌筛查方法应用的新进展[J].中国实验诊断学,2013,17(1):187-189. [5]盛秀红.血清胃蛋白酶原在慢性萎缩性胃炎和早期胃癌中的临床价值[J].医学检验与临床,2016,27(3):100-101. [6]周小微,李安全.血清抗体与快速尿素酶检测幽门螺杆菌感染的灵敏度及特异性分析[J].现代医药卫生,2016,32(22):3502-3503. [7]李晓琴,单文杰,董文福,等.胃蛋白酶原和胃泌素对萎缩性胃炎、胃癌的筛查价值及与幽门螺旋杆菌感染的关系[J].宁夏医科大学学报,2017,39(9):1062-1065. [8]薛辉,辛凤池,穆素恩,等.血清胃蛋白酶原联合G-17对萎缩性胃炎及胃癌早期诊断价值[J].现代生物医学进展,2017,17(11):2119-2122. [9]邓晓晶,郑海伦.联合检测血清胃蛋白酶原、胃泌素-17在萎缩性胃炎及胃癌筛查中的价值[J].蚌埠医学院学报,2014,39(12):1624-1627. [10]高洪亮,李宁,张清禄.血清PGⅠ、PGⅡ及G-17检测在胃癌及萎缩性胃炎中的诊断价值分析[J].癌症进展,2017,15(6):654-656. [11]姜凤全,郝赪妍,陆晓昱,等.大连市健康体检人群幽门螺杆菌感染情况调查分析[J].大连医科大学学报,2015(2):182-185. [12]陈湘林,朱净.胃蛋白酶原Ⅰ联合胃蛋白酶原Ⅱ检测在胃病中的临床应用价值分析[J].医学综述,2016,22(10):2006-2008. [13]邓娜,宫月华.胃黏膜“血清学活检”与萎缩性胃炎[J].胃肠病学和肝病学杂志,2015,24(2):136-139. [14]方小鹤,赵平,王江滨.血清胃泌素17在慢性萎缩性胃炎患者中的表达水平及意义[J].中国老年学杂志,2015,35(5):1290-1291. [15]张正勋,邱光艳.联合检测PGⅠPGR及G-17在胃癌诊断中的价值研究[J].现代医药卫生,2017,33(2):204-206. [16]魏华,张蕾蕾,李艳,等.PGⅠ、PGⅡ、G-17和Hp IgG抗体筛查慢性萎缩性胃炎和胃癌的价值[J].中国免疫学杂志,2016,32(9):1360-1363.

更新日期/Last Update: 2018-06-01